Bottom line
How much do IYH and IXJ overlap?
74% of their top holdings overlap by weight. 17 securities appear in both funds' top 25, making up 72.3% of IYH's assets and 52.8% of IXJ's. They are largely the same portfolio — owning both adds little diversification.
Updated Nov 22, 2026
Overlap at a glance
Holdings IYH and IXJ have in common
| Holding | % of IYH | % of IXJ | Overlap |
|---|---|---|---|
| Eli Lilly And Company | 15.11% | 10.93% | 10.93% |
| Johnson & Johnson | 10.17% | 7.04% | 7.04% |
| Abbvie Inc. | 7.32% | 5.12% | 5.12% |
| Unitedhealth Group Incorporated | 6.16% | 4.40% | 4.40% |
| Merck & Co., Inc. | 5.31% | 4.12% | 4.12% |
| Thermo Fisher Scientific Incorporated | 3.52% | 2.42% | 2.42% |
| Amgen Inc. | 3.42% | 2.54% | 2.54% |
| Abbott Laboratories | 3.02% | 2.05% | 2.05% |
| Gilead Sciences, Inc. | 2.66% | 2.04% | 2.04% |
| Pfizer Inc. | 2.35% | 1.78% | 1.78% |
| Bristol-myers Squibb Company | 2.20% | 1.53% | 1.53% |
| Intuitive Surgical, Inc. | 2.05% | 1.83% | 1.83% |
| Danaher Corporation | 2.03% | 1.56% | 1.56% |
| Vertex Pharmaceuticals Incorporated | 2.00% | 1.64% | 1.64% |
| Stryker Corporation | 1.86% | 1.41% | 1.41% |
| Medtronic Public Limited Company | 1.80% | 1.30% | 1.30% |
| Elevance Health, Inc. | 1.34% | 1.09% | 1.09% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in IYH
- Regeneron Pharmaceuticals, Inc. — 1.27%
- The Cigna Group — 1.20%
- Boston Scientific Corporation — 1.14%
- Hca Healthcare, Inc. — 0.99%
- Edwards Lifesciences Corporation — 0.81%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 0.80%
- Becton, Dickinson And Company — 0.78%
- Idexx Laboratories, Inc. — 0.73%
Only in IXJ
- Astrazeneca Plc — 3.76%
- Roche Holding AG — 3.75%
- Novartis AG — 3.71%
- Novo Nordisk A/s — 1.99%
- Cvs Health Corporation — 1.71%
- Gsk Plc — 1.38%
- Sanofi Sa — 1.18%
- Mckesson Corporation — 1.18%
Asset mix
| Asset type | IYH | IXJ |
|---|---|---|
| Stocks | 99.8% | 99.6% |
| Cash & short-term funds | 0.9% | 1.3% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Country mix
| Country | IYH | IXJ |
|---|---|---|
| US | 97.3% | 70.6% |
| CH | — | 10.4% |
| GB | 0.4% | 5.8% |
| JP | — | 3.7% |
| IE | 2.4% | 1.6% |
| DK | 0.2% | 2.3% |
| FR | — | 2.0% |
| DE | — | 1.6% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do IYH and IXJ overlap?
What stocks do IYH and IXJ have in common?
Should I own both IYH and IXJ?
Which holds more stocks, IYH or IXJ?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.